Solazyme Inc  

(Public, NASDAQ:SZYM)   Watch this stock  
Find more results for SZYM
+0.03 (1.38%)
Jan 30 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.12 - 2.26
52 week 2.00 - 15.00
Open 2.14
Vol / Avg. 684,091.00/1.23M
Mkt cap 175.25M
P/E     -
Div/yield     -
EPS -2.06
Shares 79.30M
Beta 1.49
Inst. own 70%
Feb 24, 2015
Q4 2014 Solazyme Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Nov 5, 2014
Q3 2014 Solazyme Inc Earnings Call
Nov 5, 2014
Q3 2014 Solazyme Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -225.96% -292.80%
Operating margin -202.14% -241.86%
EBITD margin - -229.01%
Return on average assets -41.44% -48.93%
Return on average equity -108.13% -72.23%
Employees 271 -
CDP Score - -


United States - Map
+1-650-7804777 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Solazyme, Inc. (Solazyme) makes renewable oils and other bioproducts. The Company�s technology transforms a range of plant-based sugars into oils. Its renewable products can replace or enhance oils derived from the world�s three existing sources-petroleum, plants and animal fats. The Company�s commercial focus is on selling oil-based products, including tailored oils and powdered oils, to companies that use them as intermediates and ingredients. The Company is focused on commercializing its products into three target markets which include: fuels and chemicals, nutrition, and skin and personal care. The Company is engaged in development activities with multiple partners, including Chevron U.S.A. Inc., through its division Chevron Technology Ventures (Chevron), The Dow Chemical Company (Dow), Ecopetrol S.A. (Ecopetrol), Qantas Airways Limited (Qantas) and Conopoco, Inc., doing business as Unilever (Unilever).

Officers and directors

Jerry L. Fiddler Independent Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Jonathan S. Wolfson JD Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
Tyler W. Painter Chief Financial Officer, Chief Operating Officer
Age: 42
Bio & Compensation  - Reuters
Peter J. Licari Ph.D. Chief Technology Officer
Age: 50
Bio & Compensation  - Reuters
Paul T. Quinlan General Counsel, Corporate Secretary
Age: 51
Bio & Compensation  - Reuters
James R. Craigie Director
Age: 60
Bio & Compensation  - Reuters
Peter Kovacs Director
Age: 72
Bio & Compensation  - Reuters
Gary M. Pfeiffer Director
Age: 64
Bio & Compensation  - Reuters
Michael V. Arbige Ph.D. Independent Director
Age: 60
Bio & Compensation  - Reuters
Ian T. Clark Independent Director
Age: 53
Bio & Compensation  - Reuters